The Spectralis system is the standard ophthalmic imaging system in use by UMMC Ophthalmology. Additionally, the Spectralis the only ophthalmic imaging system with the patented TruTrack Active Eye Tracking technology.

The University of Mississippi Medical Center (UMMC) has issued solicitation 9275-27-R-RFIN-00005 for the purchase of an Ophthalmic Imaging and Angiography Platform (Spectralis OCT) from Heidelberg Engineering. This procurement is being conducted as a sole source award under Certification Number SS9740, as the Spectralis system is the current standard for UMMC Ophthalmology and is the only imaging system featuring patented TruTrack Active Eye Tracking technology. The system provides an expandable diagnostic platform that integrates scanning laser fundus imaging modalities, including dye-based fluorescein angiography with high-resolution simultaneous OCT imaging. The estimated contract value is 117,900.00 dollars for a three-year period of performance in Mississippi, with the possibility for UMMC to increase spending authority for future upgrades or support. The solicitation was posted on August 12, 2026, with a response deadline of August 26, 2026. Because this is a sole source intent, interested parties wishing to object to the certification must submit a Vendor Form and the required certification from Attachment B to the designated email address by 3:00 p.m. Central Time on the deadline date.